Model N whitepaper

Five Critical Success Factors to Achieve Global Pricing Excellence in Life Sciences

2015 Annual Survey – Global Pricing in Life Sciences By Model N and High Point Solutions “The $US300 billion pharmaceuticals industry is undergoing a profound transformation. Cost containment initiatives by payers, governments and healthcare insurance organizations have created a challenging business environment with controlled pricing, promotion of generic alternatives and greater obstacles to bringing innovative drugs to market. With changing dynamics in the industry, achieving …

Sparking innovation with suppliers

WHITEPAPER by: Giles Breault, Principal and co-founder of The Beyond Group. Sammy Rashed, Principal and co-founder of The Beyond Group.  For some time now we have been delving into the question of what procurement teams imagine themselves becoming. The question may seem sophomoric on the surface but there are plenty of indicators that the same old results will no longer earn you a seat …

Tulane University – Rebuilding a Research Powerhouse

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research. Tulane University needed to create a new high-performance (HPC) infrastructure following the devastation of Hurricane Katrina. Technology from Intel and Dell brings an all-in-one cluster solution to Tulane, helping them to achieve extraordinary work across …

Elsevier whitepaper

Meeting pharmacovigilance and medical device post-market surveillance requirements

Elsevier R&D Solutions for Pharma and Life Science: extracts from Elsevier’s whitepaper  THE FUNDAMENTALS OF MONITORING LITERATURE Monitoring literature for product citations would be an impossible task if not for modern research informatics solutions. Corporate, academic and government pharmaceutical and medical research facilities produce in excess of 20 terabytes of data per day. Even with only a fraction of this data …

TGen/Dell/Intel collaboration optimizes genomic sequencing

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research. With ‘From Bench to Bedside’ as its motto, TGen launched in June 2002 and today anchors a rising biosciences hub in Phoenix, Arizona. The non-profit institute is at the forefront of efforts to bring next-generation …

bioprocess, single-use, fermentor, thermo fisher, biopharma india convention

9 Reasons To Consider A Single-Use Fermentor

This White Paper describes a new commercially available single-use fermentor that delivers scalability and meets the requirements of dense, rapidly growing microbial cultures used in modern fermentation production facilities. The many unique benefits that this new technology offers when developing new molecules in microbial systems, revamping and validating older processes, or upgrading aging equipment, will be discussed. Download whitepaper Thermo Fisher is …

Big Data Solutions: Interview with Bob Rogers @Intel

Big Data Solutions is the leading big data initiative of Intel that aims to empower business with the tools, technologies, software and hardware for managing big data. Big Data solutions is at the forefront of big data analytics and our supporting partner DNA Digest got in touch with one of our speakers at BioData World Congress–  Bob Rogers, Chief Data Scientist, …

Algorics

Press-release: Algorics analytics solution acuity selected by US CRO Lexitas to drive optimized clinical operations services

Houston, TX, USA, For Release: 8th September 2015. Algorics, a provider of clinical analytics solutions and software for the global life sciences industry, today announced that acuity, its analytics solution for risk based monitoring, has been adopted by Lexitas Pharma Services, Inc. The US Ophthalmology-focused CRO will leverage the acuity solution to bring together internal and external data sources in …

Tata Consultancy Services whitepaper

Managing Regulatory Compliance in the Pharmaceutical Industry

Changes in regulation, alongside the introduction of stringent anti-corruption legislation, are forcing pharmaceutical companies to renew their focus on compliance. Globally, pharma organizations have to embrace a holistic approach. This involves aligning complex and disparate risks and regulatory compliance activities to the overall corporate strategy. The Increased Risks in Regulatory Compliance The pharmaceutical industry is coming under increased scrutiny across …

Tata Consultancy Services whitepaper

The Clinical Trial Supplies Control Tower: Gain End to End Visibility for your Clinical Supplies

Clinical trials are getting more global, complex, larger and focused, with CROs facing added pressure to complete them faster. Dynamic market changes demonstrate a need for more collaborative IT solutions that can address new risks across the clinical trials supply chain. The control tower can be leveraged to make these clinical supply chains more responsive, beyond time zone, geography and …